NXT007 clinical trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A

This study is testing a new medicine called NXT007 for people with moderate or severe haemophilia A. It's looking at how safe it is, how it works in the body, and if it helps reduce bleeding. Both adults, teenagers, and children can take part.